We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




Simple Single-Drop Test for Vitamin B12 Deficiency Developed

By LabMedica International staff writers
Posted on 04 Nov 2014
Print article
Image: Researchers have developed a simple, sensitive test for vitamin B12 deficiency that requires only a single drop of blood (Photo courtesy of Don Erhardt and the University of British Columbia).
Image: Researchers have developed a simple, sensitive test for vitamin B12 deficiency that requires only a single drop of blood (Photo courtesy of Don Erhardt and the University of British Columbia).
Researchers have developed a novel method, requiring only a single drop of blood, to test for vitamin B12 deficiency that is sensitive enough to work on anyone, including newborn babies.

Vitamin B12 deficiency can now be tested with a single drop of blood collected from a finger prick, and then simply blotted and dried overnight on a test card consisting of filter paper. Researchers from University of British Columbia (UBC; Vancouver, BC, Canada) led by Prof. Yvonne Lamers, developed the dried blood spot card analysis to be sensitive enough to measure the amount of methylmalonic acid (MMA), indicator of B12 level. “This minimally invasive approach helps us measure deficiency in an easier and more convenient way, especially in large samples of people,” says Prof. Lamers, “Our method is the first to make dried blood spot analysis sensitive enough to test healthy people for B12 deficiency.”

The new method has the potential to be added to BC's Newborn Screening Program, which tests for treatable disorders in all infants born in BC. B12 deficiency, if not detected and treated early, can cause delayed brain development, slow learning, and digestion problems. Treatment includes injections, supplements, or dietary change. “We are interested in Dr. Lamers’ method, which may be sensitive enough to detect and confirm B12 deficiency using the blood spot cards currently collected on BC newborns,” says Hilary Vallance, director of the BC Newborn Screening Program. Roughly 5% of Canadian adults are B12 deficient and 20% show marginal sufficiency, according to Statistics Canada. In developing countries, deficiency is as high as 50% to 80% of the population.

The method also simplifies blood sample collection and testing in rural or remote areas where sophisticated lab equipment is unavailable. It is currently being used in a research project in rural Indonesia.

The study, published by Schroder TH et al. in the October 1, 2014 issue of the Journal of Nutrition, involved testing the new method on 94 healthy young women in Vancouver.

Related Links:

University of British Columbia 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article

Channels

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The revolutionary autonomous blood draw technology is witnessing growing demands (Photo courtesy of Vitestro)

Robotic Blood Drawing Device to Revolutionize Sample Collection for Diagnostic Testing

Blood drawing is performed billions of times each year worldwide, playing a critical role in diagnostic procedures. Despite its importance, clinical laboratories are dealing with significant staff shortages,... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.